The HARMONY Alliance is a European public-private partnership uniting over 100 organizations in hematology, such as hospitals, research institutes, medical associations, patient organizations, pharmaceutical companies, and IT companies. Funded by the Innovative Medicines Initiative (IMI), these organizations have joined forces to improve the care for blood cancer patients. They have established the unique HARMONY Big Data Platform, which has already identified approx. 100,000 anonymized patient records. The HARMONBY Big Data Platform is used to develop tools to rapidly select the most promising treatment strategy for an individual patient. In addition, HARMONY develops core outcome sets for blood cancers and organizes multi-stakeholder activities.
The HARMONY Alliance represents two IMI Big Data for Better Outcome projects
This years' 6th edition for HARMONY and 2nd edition of HARMONY PLUS was hosted by the European Hematology Association. Apart from the disease specific HARMONY Experts, speakers were welcomed from the American Society for Hematology (ASH), the European Medicines Agency (EMA) and EHDEN. The General Assembly kicked of with an opening speech by the EHA president.
By order of program features:
Should you be be interested to object the PPT presentations used by our speakers and session chairs, please contact: Ellen de Waal, HARMONY Alliance Lead Communications: email@example.com.
Receive the latest news. Click here to subscribe!